Polish Healthcare Undervalued based on future growth

Results

1 new

Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)

2 companies

NEUCA

Market Cap: zł3.0b

Engages in the wholesale distribution of pharmaceuticals in Poland.

NEU

zł662.00

-5.7%

-13.4%

Scope Fluidics

Market Cap: zł450.5m

A biotechnology company, designs and develops projects based on microfluidic technologies in medical diagnostics and healthcare in Poland.

SCP

zł142.20

-0.8%

-25.5%